MedVellum
MedVellum
Back to Library
Gynaecology
Urology

Urge Urinary Incontinence (OAB)

High EvidenceUpdated: 2025-12-22

On This Page

Red Flags

  • Haematuria
  • Neurological Signs (Cauda Equina / MS)
Overview

Urge Urinary Incontinence (OAB)

1. Clinical Overview

Summary

Urge urinary incontinence (UUI) is the involuntary leakage of urine accompanied by or immediately preceded by urgency. It is a component of overactive bladder (OAB) syndrome, which also includes urgency, frequency, and nocturia. UUI is caused by detrusor overactivity.

Key Facts

AspectDetail
DefinitionInvoluntary leakage with urgency
MechanismDetrusor overactivity
Key Symptom"Can't make it to the toilet in time"
Classic Scenario"Latchkey incontinence" (leaking when putting key in door)
First-LineBladder training + anticholinergics/beta-3 agonist

Clinical Pearls

  • OAB vs UUI: OAB syndrome may be "wet" (with UUI) or "dry" (urgency/frequency without leakage)
  • Neurological cause: Always ask about back pain, leg weakness, numbness (cauda equina)
  • Anticholinergic burden: Watch cognitive impairment in elderly
  • Mirabegron: Alternative without anticholinergic side effects

2. Epidemiology

Prevalence

PopulationPrevalence
Adults10-15%
Women >65Up to 30%
Increases with ageBoth sexes

Risk Factors

Risk FactorAssociation
AgeIncreases prevalence
Neurological diseaseMS, stroke, Parkinson's
ObesityIncreased bladder pressure
UTICan precipitate/worsen
Caffeine/alcoholBladder irritants
Previous pelvic surgery

3. Pathophysiology

Mechanism

Normal Bladder Filling
         ↓
Detrusor Relaxation (sympathetic)
         ↓
Gradual Stretch → First Sensation → Urge
         ↓
Voluntary Voiding (parasympathetic)

IN OAB:
Abnormal Detrusor Contractions During Filling
         ↓
Involuntary Urgency
         ↓
URGE INCONTINENCE (if can't suppress)

Causes

CategoryExamples
IdiopathicMost common
NeurogenicMS, stroke, Parkinson's, spinal cord injury
Bladder pathologyInfection, stones, tumour
Outlet obstructionBPH (secondary detrusor overactivity)

4. Clinical Presentation

Core Symptoms (OAB)

SymptomDefinition
UrgencySudden compelling desire to void, difficult to defer
FrequencyVoiding >8 times/day
NocturiaWaking ≥1 time at night to void
Urge incontinenceLeakage with urgency

Distinguishing Stress vs Urge Incontinence

FeatureStress IncontinenceUrge Incontinence
TriggerCough, sneeze, exerciseUrgency, key in door
Leak volumeSmall spurtsLarger volumes
PrecipitantsPhysical exertionSound of water, cold
WarningNoneStrong urge
MechanismSphincter weaknessDetrusor overactivity

Mixed Incontinence


Combination of stress and urge - treat predominant component first
Common presentation.
5. Clinical Examination

Examination Components

ComponentPurpose
AbdominalPalpable bladder (retention)
Vaginal/pelvicProlapse, urethral mobility
NeurologicalLower limb sensation, reflexes, perineal sensation
Cough stress testProvoke SUI

Red Flags (Urgent Referral)

FindingConcern
HaematuriaMalignancy
Recurrent UTIUnderlying pathology
Pelvic massMalignancy
Neurological signsCauda equina, MS

6. Investigations

First-Line

TestPurpose
Urinalysis / MSUExclude UTI, haematuria
Bladder diary (3 days)Document frequency, volumes, leakage
Post-void residualExclude retention

Second-Line (Specialist)

TestIndication
UrodynamicsConfirm detrusor overactivity
CystoscopyHaematuria, recurrent UTI, suspected pathology
MRI spineNeurological symptoms

7. Management

Conservative (First-Line)

InterventionDetails
Caffeine reductionCoffee, tea, cola
Fluid modification1.5-2L/day, avoid excess
Weight lossIf overweight
Bladder trainingScheduled voiding, gradually increase intervals

Bladder Training

  • Goal: increase time between voids
  • Start at current interval, gradually extend by 15-30 min
  • Duration: 6 weeks minimum

Pharmacotherapy

DrugClassNotes
OxybutyninAnticholinergicAvoid in elderly (cognitive effects)
SolifenacinAnticholinergicBetter tolerated
TolterodineAnticholinergicExtended release preferred
MirabegronBeta-3 agonistNo anticholinergic SEs, watch BP
CombinationAnticholinergic + beta-3If monotherapy fails

Anticholinergic Side Effects

  • Dry mouth
  • Constipation
  • Blurred vision
  • Cognitive impairment (elderly - avoid if possible)

Third-Line (Specialist)

TreatmentNotes
Botox (OnabotulinumtoxinA)Injection into detrusor, lasts 6-9 months
Sacral neuromodulationImplanted stimulator
Percutaneous tibial nerve stimulationWeekly sessions

8. Complications
ComplicationNotes
Quality of life impairmentSocial isolation, depression
Skin breakdownChronic moisture
Falls (elderly)Rushing to toilet
UTIPad use, incomplete emptying
Anticholinergic side effectsCognitive impairment, constipation

9. Prognosis & Outcomes
FactorOutcome
Bladder training50-80% improvement
Anticholinergics60-70% improvement
BotoxEffective for refractory cases
Chronic conditionOften requires ongoing management

10. Evidence & Guidelines
OrganisationKey Points
NICE NG123Bladder training first, avoid oxybutynin in elderly
ICSOAB definitions and terminology
EAUStepwise management approach

11. Patient / Layperson Explanation

What is overactive bladder? It's when your bladder squeezes unexpectedly, giving you a sudden strong urge to pass urine. Sometimes this can cause leakage if you can't get to the toilet quickly.

What are the symptoms?

  • Sudden urge to go ("I need to go NOW")
  • Going to the toilet very often (more than 8 times a day)
  • Getting up at night to go
  • Sometimes not making it in time

What causes it? Usually, we don't know the exact cause. It can happen with age, after stroke, or with conditions like MS or Parkinson's.

How is it treated?

  1. Lifestyle changes: Reduce caffeine, bladder training (gradually holding on longer)
  2. Medication: Tablets that relax the bladder
  3. Specialist treatments: Botox injections into the bladder, nerve stimulation

Will it get better? Most people find significant improvement with treatment. It's a very common condition - you're not alone, and there's lots we can do to help.


12. References
  1. NICE NG123. Urinary incontinence and pelvic organ prolapse in women. 2019.
  2. Gormley EA, et al. AUA/SUFU Guideline on Overactive Bladder. J Urol. 2019.
  3. Abrams P, et al. ICS Standardization Report. Neurourol Urodyn. 2010.

Last updated: 2025-12-22

At a Glance

EvidenceHigh
Last Updated2025-12-22

Red Flags

  • Haematuria
  • Neurological Signs (Cauda Equina / MS)

Guidelines

  • NICE Guidelines
  • BTS Guidelines
  • RCUK Guidelines